VivoSeq
Other

Glucocorticoid

0

Pipeline Programs↗

8

Active Trials↗

2

Companies Involved↗

Glucocorticoid is an early-stage landscape with 0 programs across 2 companies. The most active players are Spruce Biosciences, Sanofi.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

79/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Spruce Biosciences

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

47

clinical trials

Completed23 · 49%
Unknown status10 · 21%
Recruiting5 · 11%
Terminated3 · 6%
Withdrawn3 · 6%
Enrolling by invitation1 · 2%
Other2 · 4%

Clinical Trials

Trial Activity

47 trials

A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
Recruiting·UUniversity of Michigan·N/A·NCT06430528·12 enrolled
Dynamic Treatment Regiments for Glucocorticoid Tapering
Recruiting·VVA Office of Research and Development·Phase 2·NCT06072768·200 enrolled
Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP
Recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 2·NCT06686927·36 enrolled
Diesel Exhaust Induces Glucocorticoid Resistance
Recruiting·UUniversity of British Columbia·Phase 4·NCT03615742·30 enrolled
Short-term Glucocorticoid Combined with MMF for IgG4-RD
Recruiting·—·N/A·NCT06663618·63 enrolled
TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
Active, not recruiting·NNova Southeastern University·Phase 1·NCT04254627·20 enrolled
Intracochlear Injection of Glucocorticoid
Not yet recruiting·EEye & ENT Hospital of Fudan University·Phase 2·NCT07134075·150 enrolled
Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)
Enrolling by invitation·—·N/A·NCT06693856·120 enrolled
Prevention of Glucocorticoid Induced Impairment of Bone Metabolism
Completed·SSahlgrenska University Hospital·N/A·NCT04767711·50 enrolled
Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists
Completed·TThe Scripps Research Institute·Phase 2·NCT01548417·56 enrolled
Dual RElease Hydrocortisone Versus conventionAl Glucocorticoid replaceMent Therapy in Hypocortisolism (DREAM)
Completed·UUniversity of Roma La Sapienza·Phase 4·NCT02277587·89 enrolled
A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)
Completed·GGöteborg University·Phase 4·NCT03210545·30 enrolled
Short Course Glucocorticoid Treatment for PTSD
Completed·UUniversity of Wisconsin, Madison·Phase 4·NCT00204737·12 enrolled
Preoperative Glucocorticoid Use in Major Hepatectomy
Completed·UUniversity of Calgary·Phase 2/3·NCT01997658·200 enrolled
Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Completed·IIcahn School of Medicine at Mount Sinai·Phase 4·NCT01990560·8 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)